|
|
 |
|
Viewing report
|
|
|
|
Contract Research Annual Review 2011
Biopharm Knowledge Publishing, June 2011
The Complete Picture of the Contract Research Market
The contract research market grew to $28 billion last year, increasing by 15%. But that top line figure conceals a rapidly changing market and a sharp fall in profitability. Many major CROs have seen profit fall by more than 50%. The industry is rapidly re-shaping itself to match the changing needs of a pharmaceutical industry that is realigning its R&D strategies to improve effectiveness and to face a new set of demands from the market. 22 strategic alliances with CROs were announced by major pharma companies in 2010/11 as the industry was finally forced to embrace the idea of strategic outsourcing. This review provides a complete picture of the CRO market, looks at trends and developments, explains why they have happened and how they will affect the future of the industry.
Completely revised and re-formatted for 2011 the Contract Research Annual Review 2011 also contains thought provoking pieces from senior managers at leading CROs.
With 29 graphs and 18 tables, this unique 180-page review includes:
- Market size
- Market growth
- A special section on alliances
- Details of mergers, acquisitions and joint ventures.
- A 90-page news section covering leading CROs.
- Analysis of the CRO market by:
- - Type of company
- - Service offering
- - Therapy class
- Market trends including:
- - M&A activity
- - CROs in developing regions
Written by industry expert Dr. Graham Hughes the Contract Research Annual Review is essential reading for everyone involved in pharmaceutical outsourcing.
|
|
|
|
